newdrugapprovals.org
Chugai files Herceptin for post surgical Adjuvant treatment of HER2+ve breast cancer in Japan
Trastuzumab, monoclonal antibody Thursday, 7 February 2013 Chugai has filed an NDA based on evidence in the public domain with Japan MHLW seeking approval for the additional dosage and administrati…